About Index Trending news
Analyze
Top 50 Pricing
BioTime

BioTime

Work at BioTime? Add yourself to this profile

BioTime

BioTime, a biotechnology company, is engaged in biomedical R&D in regenerative medicine and stem cell therapeutics.

Elsewhere

Alexa global traffic share

Twitter followers

Latest funding Show all
Post-IPO equity
$10,550,000
Grant
$2,200,000
Israel Innovation Authority
Employees

Team size

50+
Locations
HQ
Headquarters
$2,200,000 Grant
businesswire

BioTime Announces $2.2 Million Grant for Further Development of Dry-AMD Program | Business Wire